LanzaTech Global EPS LNZA
Diluted earnings per share by quarter and over the last twelve months, from 2021.
- Last 12 months, to Jun 30, 2026
- $14.99
- Latest quarter, Q2 FY26
- $15.81
- Fiscal year 2025
- −$23.74
LanzaTech Global's earnings per share was $14.99 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $15.81.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$23.74 | n/a |
| FY2024 | −$69.69 | n/a |
| FY2023 | −$95.00 | n/a |
| FY2022 | −$1236.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $15.81 | n/a | $14.99 | |
| Q1 FY26 | −$1.77 | n/a | −$15.72 | |
| Q4 FY25 | −$0.04 | n/a | −$23.74 | |
| Q3 FY25 | $0.99 | n/a | −$37.35 | |
| Q2 FY25 | −$14.90 | n/a | −$67.38 | |
| Q1 FY25 | −$9.79 | n/a | −$66.48 | |
| Q4 FY24 | −$13.65 | n/a | −$69.69 | |
| Q3 FY24 | −$29.04 | n/a | −$66.04 | |
| Q2 FY24 | −$14.00 | n/a | −$50.00 | |
| Q1 FY24 | −$13.00 | n/a | −$50.00 | |
| Q4 FY23 | −$10.00 | n/a | −$95.00 | |
| Q3 FY23 | −$13.00 | n/a | −$412.00 |
Against its peers
Companies in Basic Materials nearest LanzaTech Global's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| LNZALanzaTech Global | $14.99 | |
| BWENBroadwind | n/m | |
| FTLFFitlife Brands | $0.62 | −23% a year |
| BTMDbiote | $0.10 | −89% a year |
| SMIDSmith Midland | $1.45 | −36% a year |
| NAGENiagen Bioscience | $0.18 | −14% a year |
| SNDSmart Sand | $0.26 | +1200% a year |
| ALTOAlto Ingredients | $0.67 | |
| FRDFriedman Industries | $3.84 | +217% a year |
| IDRIdaho Strategic Resources | $1.42 | +115% a year |
| VFFVillage Farms International | $0.18 | +100% a year |
| Peer median | $0.62 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on LanzaTech Global
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.